About Mineralys Therapeutics
Public, clinical-stage biopharmaceutical company committed to developing best-in-class, novel therapy for hypertension
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Radnor, PA
- Founded
- 2020
- Company type
- Privately Held
- Company profile name
- Mineralys Therapeutics, Inc.
At Mineralys Therapeutics we aim to redefine hypertension diagnosis, management and treatment. We are driven to break the “trial and failure” approach to hypertension management and bring a personalized approach to the management of hypertension.
Company locations
150 N. Radnor Chester Road, Suite F200, Radnor, PA 19087, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
Business areas
- Biopharma
- Biotechnology
- Medical
- Pharmaceutical
On LinkedIn
- Followers
- 12,885
- People linked to this company
- 129
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Funding raised
1,390,500,000 USD
Total reported by Crunchbase, in US dollars. This is funding raised, not company revenue or valuation.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.